Spoormans, K.; Crabbé, M.; Struelens, L.; De Saint-Hubert, M.; Koole, M.
A Review on Tumor Control Probability (TCP) and Preclinical Dosimetry in Targeted Radionuclide Therapy (TRT). Pharmaceutics 2022, 14, 2007.
https://doi.org/10.3390/pharmaceutics14102007
AMA Style
Spoormans K, Crabbé M, Struelens L, De Saint-Hubert M, Koole M.
A Review on Tumor Control Probability (TCP) and Preclinical Dosimetry in Targeted Radionuclide Therapy (TRT). Pharmaceutics. 2022; 14(10):2007.
https://doi.org/10.3390/pharmaceutics14102007
Chicago/Turabian Style
Spoormans, Kaat, Melissa Crabbé, Lara Struelens, Marijke De Saint-Hubert, and Michel Koole.
2022. "A Review on Tumor Control Probability (TCP) and Preclinical Dosimetry in Targeted Radionuclide Therapy (TRT)" Pharmaceutics 14, no. 10: 2007.
https://doi.org/10.3390/pharmaceutics14102007
APA Style
Spoormans, K., Crabbé, M., Struelens, L., De Saint-Hubert, M., & Koole, M.
(2022). A Review on Tumor Control Probability (TCP) and Preclinical Dosimetry in Targeted Radionuclide Therapy (TRT). Pharmaceutics, 14(10), 2007.
https://doi.org/10.3390/pharmaceutics14102007